NeuroSense Therapeutics Ltd. (NRSN)
NASDAQ: NRSN · Real-Time Price · USD
1.030
-0.008 (-0.77%)
May 2, 2025, 4:00 PM EDT - Market closed

NeuroSense Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
May '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Market Capitalization
2528111426-
Upgrade
Market Cap Growth
158.68%158.68%-24.68%-46.24%--
Upgrade
Enterprise Value
21276625-
Upgrade
Last Close Price
1.031.200.791.222.46-
Upgrade
PB Ratio
9.2610.74-6.102.442.94-
Upgrade
P/TBV Ratio
9.5710.74-2.442.94-
Upgrade
Debt / Equity Ratio
0.030.03-0.080.04--
Upgrade
Quick Ratio
1.781.780.814.1818.836.08
Upgrade
Current Ratio
2.212.210.844.2819.126.38
Upgrade
Return on Equity (ROE)
-2478.15%-2478.15%-494.83%-141.31%-66.63%-358.66%
Upgrade
Return on Assets (ROA)
-159.50%-159.50%-138.15%-68.90%-30.56%-208.19%
Upgrade
Return on Capital (ROIC)
-1191.29%-1191.29%-339.37%-87.59%-38.61%-228.92%
Upgrade
Earnings Yield
-41.32%-36.79%-94.21%-73.67%-12.16%-
Upgrade
FCF Yield
-41.03%-36.53%-78.14%-53.97%-5.87%-
Upgrade
Buyback Yield / Dilution
-36.38%-36.38%-18.56%-84.27%-13.13%-19.10%
Upgrade
Updated Dec 18, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q